Show Summary Details
Page of

Genetics of the MNDs 

Genetics of the MNDs
Genetics of the MNDs

Ashley Jones

and Ammar Al-Chalabi

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 December 2018

In conclusion, genetic studies of ALS are beginning to shed light on the underlying pathways that lead to motor neuron degeneration. Axonal degeneration, synaptic signalling, and RNA processing are themes that are emerging. For example, TDP-43, FUS, ANG, SMN, and ELP3 are all RNA processing proteins. After a decade of effort at understanding ALS with models based on just one gene, SOD1, we now have many genes to build a picture of the pathogenic process with several more on the way. The relationship between ALS and frontotemporal dementia is becoming clearer as genes common and distinct for the two diseases become apparent, and with our greater understanding comes the hope that a new treatment will be generated.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.